When will Siponimod be available for purchase?

Siponimod is a drug for the treatment of relapsing forms of multiple sclerosis in adults, produced by Novartis Pharmaceuticals Ltd. of Switzerland. As ofRelevant information released in July 2024, the National Medical Products Administration has approved the marketing of siponimod tablets (trade name: Wanlineng) through the priority review and approval process. This shows that siponimod tablets can be legally sold in the Chinese market. However, purchase times and channels may vary by region and pharmacy. It is recommended to contact your local pharmacy or hospital directly, or visit the official website of Novartis Pharmaceuticals to obtain the latest purchasing information and channels.